Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:human_papillomavirus
|
| gptkbp:affects |
Persistent infection risk
Potential for cancer development |
| gptkbp:associated_with |
Oropharyngeal cancer
|
| gptkbp:cause |
Cervical cancer
|
| gptkbp:clinical_trial |
Ongoing for new vaccines
|
| gptkbp:collaboration |
Part of global vaccination efforts
|
| gptkbp:community_health |
gptkb:Yes
|
| gptkbp:customs |
Associated with sexually transmitted infections
|
| gptkbp:diagnosis |
Pap smear
HPV DNA test |
| gptkbp:discovered_by |
gptkb:1980s
|
| gptkbp:diseases |
gptkb:Anal_cancer
gptkb:Penile_cancer gptkb:Vulvar_cancer Often co-infected with other HPV types |
| gptkbp:educational_resources |
Available for patients
Available for healthcare providers |
| gptkbp:epidemiology |
Worldwide distribution
|
| gptkbp:funding |
Funded by government and private sectors
|
| gptkbp:future_prospects |
Focus on long-term immunity
Focus on new therapeutic approaches |
| gptkbp:genus |
gptkb:human_papillomavirus
|
| https://www.w3.org/2000/01/rdf-schema#label |
HPV 16
|
| gptkbp:is_vulnerable_to |
gptkb:Cervarix
gptkb:Gardasil High efficacy in preventing related cancers Mild side effects possible Rare severe allergic reactions possible |
| gptkbp:legal_status |
No legal restrictions on vaccination
|
| gptkbp:prevalence |
Common in sexually active individuals
|
| gptkbp:prevention |
Vaccination
Safe sex practices |
| gptkbp:propagation_method |
Sexual contact
|
| gptkbp:provides_guidance_on |
Follow CDC recommendations
Follow WHO recommendations |
| gptkbp:public_awareness |
Increasing awareness campaigns
|
| gptkbp:research_focus |
Vaccine development
Cancer prevention |
| gptkbp:risk_factor |
Multiple sexual partners
Early sexual activity Immunocompromised status |
| gptkbp:risk_management |
Based on sexual history
|
| gptkbp:screening_test |
Colposcopy
HPV typing |
| gptkbp:screenings |
Regular cervical screening for women
|
| gptkbp:seed_dispersal |
Double-stranded DNA
|
| gptkbp:side_effect |
Significant global health issue
|
| gptkbp:symptoms |
Often asymptomatic
|
| gptkbp:treatment |
Cryotherapy
Laser therapy Investigating antiviral therapies No specific treatment for the virus itself Surgical removal of lesions |
| gptkbp:type_of |
gptkb:Alpha_papillomavirus
gptkb:High-risk_HPV |
| gptkbp:vaccine_age_recommendation |
Can be given up to age 26
Recommended for preteens |
| gptkbp:bfsParent |
gptkb:human_papillomavirus
|
| gptkbp:bfsLayer |
6
|